Portugal lets medicines up to five euros rise 2.3% in 2027
A portaria published Wednesday lets pharmacy medicines priced up to five euros rise 2.3% in 2027. It also sets exemptions and new reference countries.

Pharmacy medicines with a maximum retail price of up to five euros can cost 2.3% more in 2027, under a portaria (a government ordinance) published Wednesday in the Diário da República (Portugal’s official gazette). It takes effect Thursday, according to Observador, ECO and CNN Portugal.
The same text exempts several groups of medicines from the annual price review, including generics and biosimilars.
What the 2.3% applies to
The increase covers medicines dispensed in community pharmacies (farmácia de oficina) whose maximum retail price (PVP) is five euros or less. It is calculated on the maximum price in force when the portaria was published.
It is not automatic. It depends on the marketing authorization holders, the companies that hold the licence for each medicine. They must submit new prices by Dec. 15, 2026, and any new prices apply from Jan. 1, 2027.
Which medicines are exempt
- Non-generic, non-biosimilar medicines sold in pharmacies with a maximum price of 20 euros or less.
- Non-generic, non-biosimilar medicines used and dispensed in hospitals of the SNS (Serviço Nacional de Saúde, the national health service) with a maximum price of up to 75 euros.
- Medicines on the list of essential medicines of a critical nature, in pharmacies and in SNS hospitals.
- Generics and biosimilars.
If the annual review would push a price below 20 euros (pharmacy) or 75 euros (hospital), the price can be adjusted to that limit, depending on the type of medicine.
The exemption for generics and biosimilars still allows adjustments. Their maximum price cannot exceed that of the reference medicine after its annual review. Companies that need to adjust these prices have until Jan. 15, 2027, and the new prices apply from Feb. 1.
New reference countries
For 2027, Portugal will use Spain, France, Italy and Belgium as reference countries when setting and reviewing maximum medicine prices. The comparison applies to medicines under the maximum-price regime, whether they are sold in pharmacies or used in SNS hospitals.
The order was signed by Secretary of State for Health Ana Povo.
What changes for residents
Only medicines at or below five euros fall under the 2.3% rise, and each increase requires a company to file a new price. Price changes from the annual review start on Jan. 1, 2027, or on Feb. 1 for generics and biosimilars that need adjusting. Residents who buy a regular prescription can compare the shelf price after those dates.
Sources: Observador, ECO, CNN Portugal
Site editor: Nikita Sheikin



